Numinus Bioscience adds research space, enhances contract services,
accelerates IP development and increases psychedelic supply capacity
VANCOUVER, BC, March 9, 2021 /CNW/ - Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) ("Numinus" or the "Company"), a global leader in supporting and expanding the safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), is pleased to announce plans to significantly expand its psychedelics research laboratory by late 2021.
A 7,500 square-foot expansion will be developed and housed in an existing Numinus-leased building adjacent to the current lab. The expansion announcement comes days after Numinus received amendments to its ...
Read The Full Article On StockStreetNews.com
Get early insight on hidden secret gems on StockStreetNews . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by StockStreetNews is subject to our Terms Of Use and Disclaimer .
For further details see:
Numinus To Expand State-Of-The-Art Psychedelics Research Laboratory